15
April 2024
Argent BioPharma
Ltd.
Dr. Shlomo Sadoun Joins
Argent BioPharma Ltd Advisory Board
Argent BioPharma Ltd (Argent BioPharma or the Company), an innovative drug discovery
company within the biopharmaceutical sector, is pleased to announce
Dr. Shlomo Sadoun has joined Argent BioPharma's advisory board with
immediate effect.
Dr. Shlomo Sadoun has over 18 years
of experience in the pharmaceutical sector. Dr. Sadoun co-founded
and leads SK-Pharma Group, a global pharmaceutical company
operating in 18 countries. SK-Pharma specialises in producing and
marketing generic, specialty pharma, hybrid generics, and
biosimilar pharmaceutical products. Additionally, Dr. Sadoun serves
as the CEO of Arphio, an orphan drug company utilising proprietary
technology to promote, market, and sell orphan drugs
worldwide.
Dr. Sadoun's expertise lies in
leveraging technology to redefine business processes. He has
established strategic alliances with over 200 innovative companies
and launched more than 300 products globally, many of which were
pioneering and branded. Dr. Sadoun's adeptness in utilising
technological advancements has propelled SK-Pharma to become the
fastest-growing pharmaceutical group in Israel and beyond. Dr.
Sadoun holds a master's degree in Global Management from Salford
University and a Doctorate in Business Administration from the
Royal Academy of Economics and Technology in Switzerland, with a
focus on public health.
Roby Zomer, Managing Director and CEO of Argent BioPharma,
commented: "We are delighted to
welcome Dr. Shlomo Sadoun, an esteemed addition to our advisory
board. With his wealth of experience and expertise in the
pharmaceutical sector, Dr. Sadoun will undoubtedly provide
invaluable insights and guidance as we embark on our new strategic
direction. His appointment reaffirms our commitment to fostering a
diverse and knowledgeable advisory board, dedicated to driving
innovation and growth in our Company."
-Ends-
Authorised for release by the board of directors, for further
information please contact:
About Argent
BioPharma
Argent BioPharma is dedicated to
meeting unmet medical needs by combining PolyPharmacology and
Nanotechnology, aspiring to be a renowned global leader in the
biopharmaceutical sector. Our mission centres on researching and
developing ground-breaking treatments for worldwide health issues,
guided by strategic principles such as pioneering life science
advancements, ensuring global access, fostering continuous
innovation, and striving for industry leadership.
